Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICI) targeting PD-1/PD-L1 have emerged as contemporary treatments for a variety of cancers. However, the efficacy of antibody-based ICIs could be further enhanced. Microbiota have been demonstrated to be among the vital factors governing cancer progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Surbhi, Amatya, Sajeen Bahadur, Salmi, Sonja, Koivukangas, Vesa, Karihtala, Peeter, Reunanen, Justus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600290/
https://www.ncbi.nlm.nih.gov/pubmed/36291904
http://dx.doi.org/10.3390/cancers14205121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600290/
https://www.ncbi.nlm.nih.gov/pubmed/36291904
http://dx.doi.org/10.3390/cancers14205121

Ejemplares similares